Are Cathepsin K Inhibitors Just Another Class of Anti-Resorptives?CHAMBERS, T. J; TOBIAS, J. H.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 11, pp 4329-4331, issn 0021-972X, 3 p.Article

A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related eventsIYER, Swaminathan P; BECK, Joseph Taddeus; STEWART, A. Keith et al.British journal of haematology. 2014, Vol 167, Num 3, pp 366-375, issn 0007-1048, 10 p.Article

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)CHAREHBILI, A; VAN DE VEN, S; PEPELS, M. J et al.Annals of oncology. 2014, Vol 25, Num 5, pp 998-1004, issn 0923-7534, 7 p.Article

Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesisPATNTIRAPONG, S; SINGHATANADGIT, W; ARPHAVASIN, S et al.Journal of clinical pharmacy and therapeutics (Print). 2014, Vol 39, Num 4, pp 349-353, issn 0269-4727, 5 p.Article

Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancerDENHAM, James W; NOWITZ, Michael; NIRDOSH KUMAR GOGNA et al.BJU international (Papier). 2014, Vol 114, Num 3, pp 344-353, issn 1464-4096, 10 p.Article

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic AcidSAAD, Fred; SEGAL, Scott; EASTHAM, James et al.European urology. 2014, Vol 65, Num 1, pp 146-153, issn 0302-2838, 8 p.Article

Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisationSOUCHEK, J. J; BAINE, M. J; LAZENBY, A et al.British journal of cancer. 2014, Vol 111, Num 6, pp 1139-1149, issn 0007-0920, 11 p.Article

Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysisPEDDI, Prashanth; LOPEZ-OLIVO, Maria A; PRATT, Gregory F et al.Cancer treatment reviews. 2013, Vol 39, Num 1, pp 97-104, issn 0305-7372, 8 p.Article

Efficacy and Safety of Denosumab Versus Zoledronic Acid in Patients With Bone Metastases: A Systematic Review and Meta-analysisLEI SUN; SHIYING YU.American journal of clinical oncology. 2013, Vol 36, Num 4, pp 399-403, issn 0277-3732, 5 p.Article

Waldeström macroglobulinaemia relapsing with focal bone disease and achieving major response with single-agent zoledronic acidBAKHOUS, Aziz; HONGYUN ZHU; WAHEED, Sarah et al.British journal of haematology. 2013, Vol 163, Num 3, issn 0007-1048, p. 293Article

New and Emerging Therapies for Bone Metastases in Genitourinary CancersSAYLOR, Philip J; ARMSTRONG, Andrew J; FIZAZI, Karim et al.European urology. 2013, Vol 63, Num 2, pp 309-320, issn 0302-2838, 12 p.Article

Zoledronic Acid Inhibits Human Osteoblast ActivitiesBASSO, Fernanda G; TURRIONI, Ana Paula Silveira; HEBLING, Josimeri et al.Gerontology (Basel). 2013, Vol 59, Num 6, pp 534-541, issn 0304-324X, 8 p.Article

Bisphosphonates as antimyeloma drugsMODI, N. D; LENTZSCH, S.Leukemia. 2012, Vol 26, Num 4, pp 589-594, issn 0887-6924, 6 p.Article

Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site 'capping' phenylsDE SCHUTTER, Joris W; SHAW, Joseph; LIN, Yih-Shyan et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 18, pp 5583-5591, issn 0968-0896, 9 p.Article

Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasmaGHASSABIAN, Sussan; WRIGHT, Linda A; DEJAGER, Andrew D et al.Journal of chromatography. B. 2012, Vol 881-82, pp 34-41, issn 1570-0232, 8 p.Article

Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month resultsTAKAHASHI, Shunji; IWASE, Takuji; NOGUCHI, Shinzaburo et al.Breast cancer research and treatment. 2012, Vol 133, Num 2, pp 685-693, issn 0167-6806, 9 p.Article

Final 5-Year Results of Z-FAST Trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving LetrozoleBRUFSKY, Adam M; GRAYDON HARKER, W; ERICSON, Solveig G et al.Cancer. 2012, Vol 118, Num 5, pp 1192-1201, issn 0008-543X, 10 p.Article

Ibandronate and Calcitriol Reduces Fracture Risk, Reverses Bone Loss, and Normalizes Bone Turnover After 1TXWAGNER, Doris; AMREIN, Karin; DIMAI, Hans Peter et al.Transplantation. 2012, Vol 93, Num 3, pp 331-336, issn 0041-1337, 6 p.Article

Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/ reperfusion injury in miceFERENBACH, David A; SHELDRAKE, Tara A; DHALIWAL, Kevin et al.Kidney international. 2012, Vol 82, Num 8, pp 928-933, issn 0085-2538, 6 p.Article

Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES)HADJI, Peyman; HARTENFELS, Melanie; KYVERNITAKIS, Jannis et al.Breast cancer research and treatment. 2012, Vol 133, Num 3, pp 1089-1096, issn 0167-6806, 8 p.Article

Six Months of Parathyroid Hormone (1―84) Administered Concurrently Versus Sequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized TrialSCHAFER, Anne L; SELLMEYER, Deborah E; PALERMO, Lisa et al.The Journal of clinical endocrinology and metabolism. 2012, Vol 97, Num 10, pp 3522-3529, issn 0021-972X, 8 p.Article

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trialsLIPTON, Allan; FIZAZI, Karim; BILYNSKYY, Boris et al.European journal of cancer (1990). 2012, Vol 48, Num 16, pp 3082-3092, issn 0959-8049, 11 p.Article

The Effect of Long-term Alendronate Treatment on Cortical Thickness of the Proximal FemurUNNANUNTANA, Aasis; ASHFAQ, Kashif; TON, Quang V et al.Clinical orthopaedics and related research. 2012, Vol 470, Num 1, pp 291-298, issn 0009-921X, 8 p.Article

The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trialsTINGTING YAN; WENJIN YIN; QIONG ZHOU et al.European journal of cancer (1990). 2012, Vol 48, Num 2, pp 187-195, issn 0959-8049, 9 p.Article

The role of antiresorptive therapies in improving patient care in early and metastatic breast cancerCANDELARIA-QUINTANA, Dulcinea; DAYAO, Zoneddy R; ROYCE, Melanie E et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 355-363, issn 0167-6806, 9 p.Article